Drug Costs Archives - Page 23 of 36 - 51��Ƶ Health News

Podcast: KHN’s ‘What The Health?’ More On That Texas Lawsuit, And The Best And Worst Health Policy Stories Of The Year

The fallout continues from that Texas court decision that ruled Congress’ 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. Meanwhile, enrollment for 2019 at healthcare.gov was down, but far less than many predicted. KHN’s Julie Rovner, along with panelists Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of the Washington Examiner, discuss this, plus the best, most overhyped and nerdiest stories of 2018. Also, Rovner interviews GOP strategist and pollster Frank Luntz.

Dec. 20, 2018

5 Ways Nixing The Affordable Care Act Could Upend The Entire Health System

There could be a long legal struggle ahead over the decision by a judge in Texas to invalidate the federal health law. But if his decision stands, it would have long-lasting effects on health care from insurance coverage to Medicare payments to privacy protections.

By Julie Rovner

Dec. 20, 2018

Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs

Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from “biosimilars.” It’s a very different story in Europe.

By Sarah Jane Tribble

Dec. 20, 2018

Health Care Industry ‘Pays Tribute’ To California’s Influential Lawmakers

The leaders of California’s legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.

By Samantha Young

Dec. 15, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Dec. 14, 2018

For The Asking, A Check Is In The Mail To Help Pay For Costly Drugs

It’s a little-known secret that patients can get thousands of dollars directly from a drugmaker.

By Sarah Jane Tribble

Dec. 13, 2018

No Cash, No Heart. Transplant Centers Require Proof Of Payment.

The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say “wallet biopsies” are common.

By JoNel Aleccia

Dec. 5, 2018

The Orphan Drug Machine

Government Investigation Finds Flaws In the FDA’s Orphan Drug Program

A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.

By Sarah Jane Tribble and Sydney Lupkin

Nov. 30, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Nov. 30, 2018

Podcast: KHN’s ‘What The Health?’ Reading The Tea Leaves In Blue Wave’s Wake

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”

Nov. 29, 2018

Pharma Cash To Congress

Democrats Winning Key Leadership Jobs Have Taken Millions From Pharma

Top House Republican also received more than $1 million from drugmakers since 2007.

By Emmarie Huetteman

Nov. 29, 2018

Fish Oil Drug Looks Heart-Healthy. Just Don’t Swallow It Hook, Line And Sinker.

The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didn’t find the same promise for over-the-counter fish oil supplements when tested in healthy people.

By Shefali Luthra

Nov. 20, 2018

New Congress To Tackle Burning Health Care Issues, Including Drug Prices

KHN’s Sarah Jane Tribble discusses the twists and turns with CBS News.

Nov. 16, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Nov. 16, 2018

Podcast: KHN’s ‘What The Health?’ Doctors, Guns And Lame Ducks

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss how the Democrats’ takeover of the House and other results from the Nov. 6 elections might affect health care, and what Congress may have in store for the lame-duck session.

Nov. 15, 2018

2018 Elections

House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices

Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house committees.

By Emmarie Huetteman

Nov. 7, 2018

Podcast: KHN’s ‘What The Health?’ Open Enrollment And A Midterm Preview

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Joanne Kenen of Politico discuss the start of open enrollment for individual health insurance plans for 2019 and preview what next week’s midterm elections might mean for health policy. Plus, Barbara Feder Ostrov of KHN and California Healthline talks to Julie about the latest NPR-KHN “Bill of the Month” feature.

Nov. 1, 2018